← Leaderboards
Ira A Tabas
Columbia University Health Sciences
$44,847,082
Attributed
$50,341,966
Total exposure
26
Grants
22
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.8M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$81,534,006 · 27
By mechanism
P01$46,459,568 · 9
R01$24,234,902 · 11
R35$6,772,283 · 1
T32$2,708,214 · 1
P50$1,326,271 · 2
R13$20,000 · 2
Top collaborators
- Andrew R Marks5 shared
- Danish Saleheen4 shared
- Robert F. Schwabe4 shared
- Omid C Farokhzad2 shared
- Jinjun Shi2 shared
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Beth C Levine$23,805,454
- Ai Yamamoto$13,928,054
- Alan Richard Tall$42,229,886
- Robert E Burke$10,618,638
- Henry N Ginsberg$119,772,603
Others in their field
Top investigators on “Atherosclerosis”
- Eric A Boerwinkle · University Of Texas Hlth Sci Ctr Houston$63,519,256
- Josef Coresh · New York University School Of Medicine$60,445,875
- Daniel James Rader · University Of Pennsylvania$50,278,074
- Howard N Hodis · University Of Southern California$49,943,399
- Gary K Owens · University Of Virginia$42,472,259
- Alan Richard Tall · Columbia University Health Sciences$38,866,887
Research focus
AtherosclerosisMacrophagePathway InteractionsCellsNecrosisArterial Fatty StreakLesionBaseLinkAreaMediatingApoptosisInflammationCholesterolIn VivoApoptoticAffectInsulin ResistanceSignal TransductionProteinsAtherogenesisPreventEventNovel Therapeutics
Grant awards (134)
A Mechanistic and Translational Research Program Linking Impaired Resolution, Defective Efferocytosis, and Clonal Hematopoiesis to the Formation of Clinically Dangerous Atherosclerotic Plaques$971,319
R35 · FY2025 · HL · contact PI
Discovery of novel therapeutic targets for NASH through deep phenotyping of human knockouts and mechanistic studies$661,802
R01 · FY2025 · DK · contact PI
Macrophage Metabolic Pathways and Cellular Crosstalk in Atherosclerosis Regression$628,495
P01 · FY2025 · HL · contact PI
A Mechanistic and Translational Research Program Linking Impaired Resolution, Defective Efferocytosis, and Clonal Hematopoiesis to the Formation of Clinically Dangerous Atherosclerotic Plaques$951,902
R35 · FY2024 · HL · contact PI
Discovery of novel therapeutic targets for NASH through deep phenotyping of human knockouts and mechanistic studies$635,329
R01 · FY2024 · DK
Macrophage Metabolic Pathways and Cellular Crosstalk in Atherosclerosis Regression$632,206
P01 · FY2024 · HL · contact PI
A Mechanistic and Translational Research Program Linking Impaired Resolution, Defective Efferocytosis, and Clonal Hematopoiesis to the Formation of Clinically Dangerous Atherosclerotic Plaques$971,337
R35 · FY2023 · HL · contact PI
Discovery of novel therapeutic targets for NASH through deep phenotyping of human knockouts and mechanistic studies$661,802
R01 · FY2023 · DK
Training in Cardiovascular Translational Research$441,658
T32 · FY2023 · HL
Mechanisms of Atherogenesis in Insulin Resistance$2,130,062
P01 · FY2022 · HL · contact PI
A Mechanistic and Translational Research Program Linking Impaired Resolution, Defective Efferocytosis, and Clonal Hematopoiesis to the Formation of Clinically Dangerous Atherosclerotic Plaques$971,347
R35 · FY2022 · HL · contact PI
Discovery of novel therapeutic targets for NASH through deep phenotyping of human knockouts and mechanistic studies$677,927
R01 · FY2022 · DK
CaMKII/MK2 Signaling in Cardiometabolic Disease$550,142
P01 · FY2022 · HL · contact PI
Training in Cardiovascular Translational Research$486,363
T32 · FY2022 · HL
Administrative Core$165,501
P01 · FY2022 · HL · contact PI
Mechanisms of Atherogenesis in Insulin Resistance$2,130,062
P01 · FY2021 · HL · contact PI
A Mechanistic and Translational Research Program Linking Impaired Resolution, Defective Efferocytosis, and Clonal Hematopoiesis to the Formation of Clinically Dangerous Atherosclerotic Plaques$971,355
R35 · FY2021 · HL · contact PI
TAZ and YAP in Non-Alcoholic Steatohepatitis and its Complications$664,138
R01 · FY2021 · DK · contact PI
Training in Cardiovascular Translational Research$605,154
T32 · FY2021 · HL
CaMKII/MK2 Signaling in Cardiometabolic Disease$550,142
P01 · FY2021 · HL · contact PI
Administrative Core$165,501
P01 · FY2021 · HL · contact PI
Mechanisms of Atherogenesis in Insulin Resistance$2,130,062
P01 · FY2020 · HL · contact PI
A Mechanistic and Translational Research Program Linking Impaired Resolution, Defective Efferocytosis, and Clonal Hematopoiesis to the Formation of Clinically Dangerous Atherosclerotic Plaques$979,027
R35 · FY2020 · HL · contact PI
TAZ and YAP in Non-Alcoholic Steatohepatitis and its Complications$664,138
R01 · FY2020 · DK · contact PI
Training in Cardiovascular Translational Research$597,144
T32 · FY2020 · HL
CaMKII/MK2 Signaling in Cardiometabolic Disease$550,142
P01 · FY2020 · HL · contact PI
Administrative Core$165,501
P01 · FY2020 · HL · contact PI
Mechanisms of Atherogenesis in Insulin Resistance$2,130,062
P01 · FY2019 · HL · contact PI
A Mechanistic and Translational Research Program Linking Impaired Resolution, Defective Efferocytosis, and Clonal Hematopoiesis to the Formation of Clinically Dangerous Atherosclerotic Plaques$955,996
R35 · FY2019 · HL · contact PI
Enhancing Inflammation Resolution in Atherosclerosis via Targeted Nanoparticle-Mediated Delivery of Biologics$733,763
R01 · FY2019 · HL · contact PI
TAZ and YAP in Non-Alcoholic Steatohepatitis and its Complications$664,138
R01 · FY2019 · DK · contact PI
Training in Cardiovascular Translational Research$577,895
T32 · FY2019 · HL
CaMKII/MK2 Signaling in Cardiometabolic Disease$550,142
P01 · FY2019 · HL · contact PI
Administrative Core$165,501
P01 · FY2019 · HL · contact PI
Mechanisms of Atherogenesis in Insulin Resistance$1,985,122
P01 · FY2018 · HL · contact PI
Enhancing Inflammation Resolution in Atherosclerosis via Targeted Nanoparticle-Mediated Delivery of Biologics$738,492
R01 · FY2018 · HL · contact PI
TAZ and YAP in Non-Alcoholic Steatohepatitis and its Complications$664,138
R01 · FY2018 · DK · contact PI
"MerTK Cleavage and Signaling in Atherosclerosis"$493,137
R01 · FY2018 · HL · contact PI
CaMKII/MK2 Signaling in Cardiometabolic Disease$405,203
P01 · FY2018 · HL · contact PI
Administrative Core$165,502
P01 · FY2018 · HL · contact PI
CaMKII/MK2 Signaling in Cardiometabolic Disease$138,148
R01 · FY2018 · HL · contact PI
Mechanisms of Atherogenesis in Insulin Resistance$2,103,765
P01 · FY2017 · HL · contact PI
Enhancing Inflammation Resolution in Atherosclerosis via Targeted Nanoparticle-Mediated Delivery of Biologics$746,562
R01 · FY2017 · HL · contact PI
The UPR and CaMKIIg in Atherosclerosis and Insulin Resistance$543,352
P01 · FY2017 · HL · contact PI
"MerTK Cleavage and Signaling in Atherosclerosis"$493,137
R01 · FY2017 · HL · contact PI
Mechanisms and Consequences of Stress-Induced Macrophage Death in Atherosclerosis$400,000
R01 · FY2017 · HL · contact PI
Administrative Core$163,457
P01 · FY2017 · HL · contact PI
Mechanisms of Atherogenesis in Insulin Resistance$2,103,765
P01 · FY2016 · HL · contact PI
Enhancing Inflammation Resolution in Atherosclerosis via Targeted Nanoparticle-Mediated Delivery of Biologics$769,326
R01 · FY2016 · HL · contact PI
The UPR and CaMKIIg in Atherosclerosis and Insulin Resistance$543,352
P01 · FY2016 · HL · contact PI
"MerTK Cleavage and Signaling in Atherosclerosis"$508,137
R01 · FY2016 · HL · contact PI
Mechanisms and Consequences of Stress-Induced Macrophage Death in Atherosclerosis$400,000
R01 · FY2016 · HL · contact PI
Administrative Core$163,457
P01 · FY2016 · HL · contact PI
Mechanisms of Atherogenesis in Insulin Resistance$2,072,208
P01 · FY2015 · HL · contact PI
The UPR and CaMKIIg in Atherosclerosis and Insulin Resistance$535,203
P01 · FY2015 · HL · contact PI
Mechanisms and Consequences of Stress-Induced Macrophage Death in Atherosclerosis$394,000
R01 · FY2015 · HL · contact PI
Mechanisms of Defective Efferocytosis in Atherosclerosis$394,000
R01 · FY2015 · HL · contact PI
Administrative Core$161,004
P01 · FY2015 · HL · contact PI
Mechanisms of Atherogenesis in Insulin Resistance$2,061,690
P01 · FY2014 · HL · contact PI
The UPR and CaMKIIg in Atherosclerosis and Insulin Resistance$532,486
P01 · FY2014 · HL · contact PI
Autophagy in Advanced Atherosclerosis$455,777
R01 · FY2014 · HL · contact PI
Mechanisms and Consequences of Stress-Induced Macrophage Death in Atherosclerosis$392,000
R01 · FY2014 · HL · contact PI
Mechanisms of Defective Efferocytosis in Atherosclerosis$392,000
R01 · FY2014 · HL · contact PI
Administrative Core$160,186
P01 · FY2014 · HL · contact PI
Mechanisms of Atherogenesis in Insulin Resistance$1,717,466
P01 · FY2013 · HL · contact PI
The UPR and CaMKIIg in Atherosclerosis and Insulin Resistance$543,351
P01 · FY2013 · HL · contact PI
Autophagy in Advanced Atherosclerosis$442,755
R01 · FY2013 · HL · contact PI
Mechanisms and Consequences of Stress-Induced Macrophage Death in Atherosclerosis$400,000
R01 · FY2013 · HL · contact PI
Mechanisms of Defective Efferocytosis in Atherosclerosis$380,800
R01 · FY2013 · HL · contact PI
Administrative Core$163,458
P01 · FY2013 · HL · contact PI
Autophagy in Advanced Atherosclerosis$465,077
R01 · FY2012 · HL · contact PI
Mechanisms of Defective Efferocytosis in Atherosclerosis$400,000
R01 · FY2012 · HL · contact PI
The Unfolded Protein Response in Sterol Cytoxicity$398,475
R01 · FY2012 · HL · contact PI
Mechanisms of Atherogenesis in Insulin Resistance$2,116,915
P01 · FY2011 · HL · contact PI
Molecular Links Between Insulin Resistance and Macrophage Death in Atherosclerosi$546,743
P01 · FY2011 · HL · contact PI
Autophagy in Advanced Atherosclerosis$465,077
R01 · FY2011 · HL · contact PI
The Unfolded Protein Response in Sterol Cytoxicity$402,500
R01 · FY2011 · HL · contact PI
Administrative Core$164,483
P01 · FY2011 · HL · contact PI
ROLE OF CAMKII IN HEPATIC GLUCONEOGENESIS$12,768
P41 · FY2011 · RR · contact PI
Mechanisms of Atherogenesis in Insulin Resistance$2,116,915
P01 · FY2010 · HL · contact PI
Macrophage Death in Plaque Vulnerability$578,101
P01 · FY2010 · HL · contact PI
Molecular Links Between Insulin Resistance and Macrophage Death in Atherosclerosi$546,743
P01 · FY2010 · HL · contact PI
Interaction of Atherogenic Lipoproteins with Macrophages$472,036
R01 · FY2010 · HL · contact PI
The Unfolded Protein Response in Sterol Cytoxicity$402,500
R01 · FY2010 · HL · contact PI
Administrative Core$164,483
P01 · FY2010 · HL · contact PI
2010 Lipoprotein Metabolism GRC$10,000
R13 · FY2010 · HL · contact PI
Mechanisms of Atherogenesis in Insulin Resistance$2,116,915
P01 · FY2009 · HL · contact PI
Macrophage Death in Plaque Vulnerability$560,982
P01 · FY2009 · HL · contact PI
Molecular Links Between Insulin Resistance and Macrophage Death in Atherosclerosi$546,743
P01 · FY2009 · HL · contact PI
Interaction of Atherogenic Lipoproteins with Macrophages$467,636
R01 · FY2009 · HL · contact PI
The Unfolded Protein Response in Sterol Cytoxicity$402,500
R01 · FY2009 · HL · contact PI
Administrative Core$164,483
P01 · FY2009 · HL · contact PI
Mechanisms of Atherogenesis in Insulin Resistance$2,116,915
P01 · FY2008 · HL · contact PI
Molecular Links Between Insulin Resistance and Macrophage Death in Atherosclerosi$546,743
P01 · FY2008 · HL · contact PI
Macrophage Death in Plaque Vulnerability$536,460
P01 · FY2008 · HL · contact PI
Interaction of Atherogenic Lipoproteins with Macrophages$444,938
R01 · FY2008 · HL · contact PI
The Unfolded Protein Response in Sterol Cytoxicity$402,500
R01 · FY2008 · HL · contact PI
Administrative Core$164,483
P01 · FY2008 · HL · contact PI
Mechanisms of Atherogenesis in Insulin Resistance$2,160,116
P01 · FY2007 · HL · contact PI
Molecular Links Between Insulin Resistance and Macrophage Death in Atherosclerosi$557,902
P01 · FY2007 · HL · contact PI
Macrophage Death in Plaque Vulnerability$534,222
P01 · FY2007 · HL · contact PI
Interaction of Atherogenic Lipoproteins with Macrophages$440,792
R01 · FY2007 · HL · contact PI
The Unfolded Protein Response in Sterol Cytotoxicity$387,569
R01 · FY2007 · HL · contact PI
Administrative Core$167,838
P01 · FY2007 · HL · contact PI
Macrophage Death in Plaque Vulnerability$479,118
P01 · FY2006 · HL · contact PI
Interaction of Atherogenic Lipoproteins with Macrophages$455,982
R01 · FY2006 · HL · contact PI
The Unfolded Protein Response in Sterol Cytoxicity$399,144
R01 · FY2006 · HL · contact PI
Spingomyelinase in atherosclerosis and foam cell biology$232,242
P50 · FY2006 · HL · contact PI
CORE D--PATHOLOGY$78,914
P50 · FY2006 · HL · contact PI
The Unfolded Protein Response in Sterol Cytoxicity$408,750
R01 · FY2005 · HL
Macrophage Death in Plaque Vulnerability$402,500
R01 · FY2005 · HL
Spingomyelinase in atherosclerosis and foam cell biology$226,658
P50 · FY2005 · HL
CORE D--PATHOLOGY$76,911
P50 · FY2005 · HL
Conference on Cellular Biology of Atherosclerosis$10,000
R13 · FY2005 · HL
INTERACTION OF ATHEROGENIC LIPOPROTEINS WITH MACROPHAGES$413,876
R01 · FY2004 · HL
The Unfolded Protein Response in Sterol Cytotoxicity$408,750
R01 · FY2004 · HL
Spingomyelinase in atherosclerosis and foam cell biology$221,238
P50 · FY2004 · HL
CORE D--PATHOLOGY$74,966
P50 · FY2004 · HL
INTERACTION OF ATHEROGENIC LIPOPROTEINS WITH MACROPHAGES$404,029
R01 · FY2003 · HL
INTERACTION OF ATHEROGENIC LIPOPROTEINS WITH MACROPHAGES$393,760
R01 · FY2002 · HL
Macrophage death and lipid metabolism in atherosclerosis$268,239
P01 · FY2002 · HL
FORM CELL APO (A)/LP(A) RECEPTOR--CLONING AND FUNCTION$230,098
R01 · FY2002 · HL
CORE--PATHOLOGY$0
P50 · FY2002 · HL
Spingomyelinase in atherosclerosis and foam cell biology$0
P50 · FY2002 · HL
INTERACTION OF ATHEROGENIC LIPOPROTEINS WITH MACROPHAGES$399,920
R01 · FY2001 · HL
Macrophage death and lipid metabolism in atherosclerosis$268,239
P01 · FY2001 · HL
FORM CELL APO (A)/LP(A) RECEPTOR--CLONING AND FUNCTION$220,056
R01 · FY2001 · HL
CORE--PATHOLOGY$0
P50 · FY2001 · HL
ARTERIAL SPHINGOMYELINASE, PROTEOGLYCANS AND ATHEROGENESIS$0
P50 · FY2001 · HL
INTERACTION OF ATHEROGENIC LIPOPROTEINS WITH MACROPHAGES$360,935
R01 · FY2000 · HL
Macrophage death and lipid metabolism in atherosclerosis$268,239
P01 · FY2000 · HL
FORM CELL APO (A)/LP(A) RECEPTOR--CLONING AND FUNCTION$220,056
R01 · FY2000 · HL
CORE--PATHOLOGY$207,671
P50 · FY2000 · HL
ARTERIAL SPHINGOMYELINASE, PROTEOGLYCANS AND ATHEROGENESIS$207,671
P50 · FY2000 · HL